No abstract available
MeSH terms
-
Carcinoma, Renal Cell / drug therapy*
-
Clinical Trials as Topic
-
Drug Administration Schedule
-
Humans
-
Interleukin-2 / administration & dosage
-
Interleukin-2 / adverse effects
-
Interleukin-2 / therapeutic use*
-
Kidney Neoplasms / drug therapy*
-
Killer Cells, Lymphokine-Activated
-
Melanoma / drug therapy*
-
Recombinant Proteins / adverse effects
-
Recombinant Proteins / therapeutic use
Substances
-
Interleukin-2
-
Recombinant Proteins